Emeis Stock Drops 2.5% and Tests Support at €13.64 Again
The health services group's stock declines in an otherwise rising SBF 120. The stock briefly dips below its technical threshold before recovering, extending a sequence of volatile sessions. The movement occurs in a Parisian context marked by caution towards cyclical stocks.
The Stock Briefly Dips Below Its €13.64 Support Before Recovering
Emeis stock falls 2.5% to €13.65 in early afternoon trading, while the SBF 120 index is up 0.24%. The stock touched a session low of €13.61, momentarily dipping below its €13.64 support, before climbing back above. This movement extends the decline observed on Monday, already noted when the stock was among the biggest losers in the SBF 120. The price is currently below its three moving averages: MM20 at €14.12 (a gap of -3.33%), MM50 at €14.39, and MM200 at €13.97, indicating a short-term loss of momentum. The RSI at 42 remains neutral, with no extreme signals. Over one year, the performance remains positive at nearly 30%, but the stock has lost over 7% in the past month.
A Bearish Session in an Otherwise Bullish Parisian Market
The stock's decline contrasts with the overall tone of the Paris market, with the CAC 40 up 0.35% and the SBF 120 up 0.24%. The European session remains fragile, however, with the DAX down nearly 1% and the VIX up more than 9% to 18.87 points, indicating a resurgence of nervousness imported from Wall Street, where the Nasdaq shows a marked decline. The overall environment continues to be influenced by the more restrictive turn of major central banks mentioned in an analysis on June 21, which weighs on valuations in sectors sensitive to interest rates. Operationally, Emeis has been under pressure for several sessions, with its price having tested a technical support in early June. The holding of the €13.64 threshold, retested this Wednesday, will be the next numerical reference to watch in the upcoming sessions.
